跳至主要内容
临床试验/CTRI/2022/07/043863
CTRI/2022/07/043863进行中(未招募)2 期

Interstitial brachytherapy in cancer cervix: A phase II randomized controlled trials of two different treatment schedules

Dr Partha Sarathi Bhattacharyya0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. All biopsy-proven Ca. cervix cases (squamous, adenocarcinoma, adeno-squamous histology) between the age of 18 to 70 years with Karnofsky Performance Status or above 70% will be considered.
  • 2. Patients with carcinoma cervix Stage IIB – IIIB that underwent external beam radiotherapy (EBRT), irrespective of lymph node involvement that are fit for interstitial brachytherapy (ISBT) will be considered.

排除标准

  • 1. Diabetes mellitus (DM)
  • 2. Chronic obstructive pulmonary disease (COPD),
  • 3. Ischemic heart disease (IHD)
  • 5. HBsAg+
  • 6. Prior malignancies
  • 7. Mental illness
  • 8. Patients unfit for epidural anesthesia
  • 9. Pregnant and lactating women.
  • 10. Renal dysfunction (S. creatinine >1mg/dl)
  • 11. Hepatic dysfunction (S. bilirubin >1mg/dl)

研究者

发起方
Dr Partha Sarathi Bhattacharyya

相似试验